Training, Tools, and Teamwork: Addressing Psychotropic Medication Use in Developmental Disabilities
Friday May 23, 12:30PM – 2:00PM (Eastern Daylight Time)
Too many people with intellectual and developmental disabilities are prescribed psychotropic medications they may not need. This webinar explores practical ways to change that.
Learn how two UK initiatives are tackling overprescribing and putting people with disabilities at the centre of medication decisions—through better training, clear communication tools, and strong collaboration.

Shoumitro Deb MBBS FRCPsych MD
Visiting Clinical Professor of Neuropsychiatry
Faculty of Medicine, Division of Brain Sciences
Imperial College London, UK
Professor Emeritus Shoumitro Deb is a Visiting Clinical Professor of Neuropsychiatry at the Department of Brain Sciences at Imperial College London, UK. His research interests include neuropsychiatry of traumatic brain injury (TBI), epilepsy and intellectual disabilities (ID), dementia and Down's syndrome, and psychopharmacology of aggression in people with TBI and ID. He has over 400 publications, including 12 books and over 65 book chapters and has made over 300 presentations at national and international conferences. His citation index is 10253, the h-index is 52, and the i10 index is 151 (23.04.25). He has received over 34 research grants and led a research team of over 20 members. He led MSc courses on Psychological Medicine and Epilepsy and coordinated modules for the MSc in Neuropsychiatry and the International ID program. He developed the first-ever free online international training resource, SPECTROM (https://spectrom.wixsite.com/project), for caregivers to help reduce the overmedication of people with ID. He led the international guideline for mental health medicine prescribing for behaviours of concern in adults with ID (World Psychiatry, 2009). He conducted the first-ever comprehensive neuropsychiatric assessment of TBI patients (AJP, BJP, JNNP, 1999). He developed patient and family-carer-led assessment tools for TBI patients (NDT, 2007). He developed a dementia screening questionnaire for adults with ID (DSQIID) (BJP, 2007), which has been translated and validated worldwide in over 24 languages. He led the European guideline for the assessment and diagnosis of mental illness in adults with ID (EJP, 2022). He conducted the first ever comprehensive assessment of psychopathology in adults with ID and epilepsy (BJP, 1991). He conducted the first ever comprehensive assessment of psychopathology in adults with ID (JIDR, 2001). He has been a member of several UK NICE, the World Psychiatric Association and the WHO workgroups.

Sue Caton
Reader, Department of Social Care and Social Work
Faculty of Health and Education
Manchester Metropolitan University
Dr Sue Caton is an Associate Professor in Intellectual Disabilities Research in the Department of Social Care and Social Work at Manchester Metropolitan University, UK. Sue completed a PhD on the transition to adult life at the same university in 2002 and has carried out research with people with intellectual disabilities for the last 25 years. Sue’s research uses a social justice approach to identifying and understanding both social and health inequalities. This has included research around digital participation, the social and health inequalities that materialized during the COVID-19 pandemic, and more recently the Medications and My Mental Health co-produced project which aimed to develop a toolkit of information and resources to support people with intellectual disabilities to become more confident shared decision-makers about their mental health medications: https://medmentalhealth.net/. Methodologically, Sue’s research is primarily qualitative, using co-production and participatory and creative approaches. Most of Sue’s research is carried out in partnership with small organizations such as self-advocacy groups and includes co-researchers with learning disabilities as part of the research team.